The relationship between psoriasis and depression: A multiple mediation model

Łakuta, Patryk; Marcinkiewicz, Kamil; Bergler‐Czop, Beata; Brzeźińska-Wcisło, Ligia

doi:10.1016/j.bodyim.2016.08.004

Cited by 23 publications

(32 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stigmatization is a critical mediator of the relationship between psoriatic skin lesions and clinical depression. 36 Perceived depreciation of social touch highly correlates with depressive symptoms in patients with psoriasis. 24 Symptoms of depression and anxiety are more strongly correlated with stigmatization than with the physical extent of their skin involvement.…”

Section: Resultsmentioning

confidence: 99%

“…35 Patients with psoriasis may develop maladaptive coping mechanisms to help them avoid social situations. 36 There is a significant positive correlation between patients who agree with the statement, "psoriasis dictates how I lead my life," and feelings of stigmatization (feeling that others avoid them due to psoriasis, do not understand the experience of having psoriasis, and needing to conceal their psoriasis from others). 22 Up to 90% of patients with psoriasis avoid social activities due to their disease, such as avoid swimming and sunbathing, visiting a hair salon, playing sports, using communal baths and showers, and even leaving their homes.…”

Section: How Psoriasis Sufferers Experience Stigmamentioning

confidence: 99%

See 1 more Smart Citation

Stigmatization in Psoriasis

Chen

Beck

Tan

et al. 2018

Journal of Psoriasis and Psoriatic Arthritis

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: How Psoriasis Sufferers Experience Stigmamentioning

confidence: 99%

Stigmatization in Psoriasis

Chen

Beck

Tan

et al. 2018

Journal of Psoriasis and Psoriatic Arthritis

View full text Add to dashboard Cite

show abstract

“…Studies have shown that psoriasis is still perceived as contagious disease and a result of poor personal hygiene . International studies document both a high perceived burden of social isolation and (self‐)stigmatization as well as effects on the body image of those affected, which is associated with depressive symptoms . However, stigmatization itself was shown to be the most powerful predictor of depressive symptoms for psoriasis patients.…”

Section: Introductionmentioning

confidence: 99%

Translating the WHA resolution in a member state: towards a German programme on ‘Destigmatization’ for individuals with visible chronic skin diseases

Augustin

Mrowietz

Luck-Sikorski

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background Even today, a substantial number of individuals with visible skin diseases still suffer from incomprehension and stigmatization. About 10 million people are affected by such diseases in Germany. The WHO strongly urges member states to take measures against stigmatization in skin diseases. Objectives Objectives are the development of an action programme to raise awareness and address stigmatization. Therefore, conception, development and testing of interventions for the destigmatization of persons with skin diseases in Germany will be carried out. Methods A series of actions addressing decision makers, politicians and the Federal Ministry of Health were initiated, all based on the World Health Assembly (WHA). Argumentation was largely based on data from health services research. Supported by the Federal Ministry of Health, a concept against stigmatization was developed by an expert consortium of researchers, dermatologists and patients. Specific strategies of structured destigmatization between those affected and those not will be developed and scientifically evaluated. Results The activities addressed to politics were – to a large extent – successfully and financially supported by a 3‐year programme (2018–2020), designed to develop interventions against stigma. It was funded by the Federal Ministry of Health. The project includes conception and development, intervention and evaluation, data analyses and development of a long‐term concept. Conclusions The WHO's call against stigmatization in psoriasis (resolution WHA67.9 and global report on psoriasis 2016) was taken into account and developed into a destigmatization programme supported by the German government and German politicians. This has been achieved by successful collaborations between dermatologists, researchers, patients and policymakers. Next step will be the testing of interventions in situations and surroundings, where stigmatization usually occurs. The data will be used for the implementation of a long‐term concept that can be used to continue destigmatization in Germany far beyond the project′s initial phase.

show abstract

“…HV and SSc patients meeting the ACR/EULAR criteria for SSc were recruited during their usual medical follow-up. 6 All subjects attended two visits, 7 days apart. At each visit, skin visco-elasticity was measured using skin cutometry (Cutometerâ dual MPA 580, 6 mm probe) at several different eight hairless skin sites, to assess intraday and 7-day reproducibility of the skin's visco-elastic properties.…”

Section: Editormentioning

confidence: 99%

“…5 Factors such as these are likely to have a profoundly negative effect upon well-being in the context of psoriasis and may serve to precipitate or propagate depressive illness. 6 Therapeutic studies in psoriasis grant further insights into the mechanisms underlying depression in this patient group. The authors assert that anti-inflammatory treatment can be used to treat depression, but biologic therapies, while significantly reducing the severity of depressive symptoms, have not consistently induced remission of depression.…”

mentioning

confidence: 99%